All In MedTech

Device Trial Radar · NCT02660645

Blue Light Cystoscopy With Cysview® Registry

Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

4,400

Planned (sponsor's estimate)

Start

Apr 2014

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
PhotocureNot on our public-company list
Sponsor type
Industry
Collaborators
Catalyst Pharmaceutical Research
First posted
Jan 21, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Conditions

  • Bladder Cancer

Interventions

  • Hexaminolevulinate hydrochloride (HCL)Drug

    Instillation in bladder

  • Karl Storz D-Light C Photodynamic Diagnostic (PDD) systemDevice

    Cystoscopy procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of detection of bladder malignanciesTime frame: 5 years

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • The University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Mayo Clinic

    Phoenix, Arizona · Recruiting

  • USC/Norris Comprehensive Cancer Center

    Los Angeles, California · Recruiting

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.